Results 81 to 90 of about 963 (180)

Comparison of the Efficacy and Safety of Levocetirizine versus Bilastine for the Treatment of Chronic Spontaneous Urticaria in the Pediatric Population: An Observer-blinded Randomized Control Trial

Indian Journal of Paediatric Dermatology
Background: Chronic spontaneous urticaria (CSU) refers to urticaria that has no specific cause or trigger, present on most days of the week for 6 weeks or more.
Debashree Sahoo, Maitreyee Panda, Ajaya Kumar Jena, Anil Kumar Panda   +3 more
doaj   +1 more source

UV SPECTROPHOTOMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF BILASTINE USING EXPERIMENTAL DESIGN FOR ROBUSTNESS [PDF]

Bilastine is a novel nonsedative H1-receptor antagonist, which may be used for the symptomatic treatment of chronic idiopathic urticaria (CU). This study describes the validation of an UV spectrophotometric method for quantitative determination of ...
Rossi Brabo, Gabriela, Bajerski, Lisiane, Soldateli Paim, Clésio, Dias Marques, Isadora, Donadel Malesuik, Marcelo, Tassinari da Silva, Andressa   +5 more
core   +1 more source

Formulation and evaluation of fast dissolving tablet-bilastine [PDF]

In the present, study to establish Fast dissolving tablets of Bilastine by using different ratio of superdisintegrants. The tablets were prepared by using two superdisintegrants( croscarmellose sodium, sodium starch glycolate) in different composition ...
Mohit Changra, Satinder Kakkar, Ramandeep Singh   +2 more
core   +1 more source

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria

Therapeutics and Clinical Risk Management, 2013
Belen Sadaba, Jose Ramon Azanza, Almundena Gomez-Guiu, Raquel RodilClinical Pharmacology Service, Clinica Universidad de Navarra, Navarra, SpainAbstract: Bilastine is a second generation antihistamine indicated for the treatment of seasonal or perennial ...
Sadaba B, Azanza JR, Gomez-Guiu A, Rodil R   +3 more
doaj  

Cognitive performance effects of bilastine 20 mg during 6 hours at 8000 ft cabin altitude

, 2016
INTRODUCTION: Bilastine is a new oral, second generation antihistamine used in the symptomatic treatment of allergic rhinoconjunctivitis and urticaria.
Simons, M., Labeaga, L., Valk, P.J.L., Jetten, A.M., Valiente, R.   +4 more
core   +1 more source

A perception-based survey to understand the role of a combination of bilastine and montelukast in the management of allergic rhinitis

The Journal of Association of Chest Physicians
Aim: To understand the clinical perceptions and role of a combination of bilastine and montelukast in the management of allergic rhinitis (AR). Methods: A cross-sectional, observational survey was conducted through a digital questionnaire among 445 ...
Vikrant Deshmukh, Mahavir Bagrecha, Sanjay Sathe, Swapnil Kadam, G. Gananathan, Carlton Periera, Vaishali Gupte, Gurmeet Kaur Thakur, Manjushree Naik Patil   +8 more
doaj   +1 more source

A Comparative Study to Evaluate the Effects of Fluticasone Nasal Spray with Oral Bilastine Versus Mometasone Nasal Spray with Oral Bilastine in Patients of Moderate to Severe Rhinitis

, 2023
Background: Rhinitis is defined as inflammation of the lining of the nose and is characterized by nasal symptoms including rhinorrhea, sneezing, nasal blockage and itching of the nose.
Mishra, Shiva
core  

Development of expeditious RP-HPLC method for simultaneous estimation of bilastine and montelukast in fixed dosage combination

Journal of Applied Pharmaceutical Research
Background: Bilastine and montelukast are used to treat allergic rhinitis and chronic urticaria. Due to the recent increase in highly allergic disorders, demand for this combination has risen. Therefore, for regular quality control analysis, a new, rapid,
Revathi Boddu, Jithendar Reddy Mandhadi, Narender Boggula, Rajeshwar Vodeti, Suchitra Duddagi   +4 more
doaj   +1 more source

Understanding the ionization pattern of bilastine, histamine H1 receptor antagonist

Bilastine is a second-generation oral H1 antihistamine approved for the use in symptomatic treatment of allergic rhinoconjunctivitis and urticaria with the advantage of its favourable tolerability profile and the long duration of action [1]. ..
Popović-Nikolić, Marija, Nikolić, Katarina, Popović, Gordana, Oljačić, Slavica   +3 more
core   +2 more sources

Balanced discussion of second-generation antihistamines' data

Therapeutics and Clinical Risk Management, 2016
Rossen Boev,1 Jürgen WG Bentz2 1UCB Pharma, Bulle, Switzerland; 2UCB Pharma, Brussels, Belgium It is with interest that we read the paper “Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine ...
Boev R, Bentz JWG
doaj